Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Navigating the Longitudinal Effects of Early Treatment Strategies and Relapse on Clinical, Cognitive, and Functional Outcomes: A 20-Year Follow-up of First Episode Psychosis
A Randomized, Open-label, Multicenter, Two-formulation, Multiple-dose, Parallel-design Bioequivalence Study of Paliperidone Palmitate Injection (3M) in Chinese Patients With Schizophrenia
A Cohort Study of Disease Prediction Model for High-risk Population With Bipolar Disorder
Read the official source — NCT07031661The Establishment of Disease Prediction Model for High-risk Population With Bipolar Disorder Based on Multimodal Data: A Multicenter, Large Sample, Prospective Cohort Study
A Novel Digital Cognitive Intervention Targeting Intrusive Memories Among Trauma-Exposed Individuals: A Randomised Clinical Trial
A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China
A Randomized, Double-Blind, Placebo-Controlled, Dose- Ascending Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of LPM787000048 Maleate Extended-Release Tablets (LY03020) in Chinese Adult Healthy Subjects and/or Subjects With Stable Schizophrenia
Randomized Controlled Study on Home-Based Digital Therapy Intervention for School-Aged Children With Attention Deficit Hyperactivity Disorder Based on Brain-Controlled Games
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
Read the official source — NCT07286175Researchers compare brenipatide with placebo, both added to usual treatment, to find out whether it delays a new mood episode in adults with bipolarity. They monitor changes in symptoms and the safety of the added medicine.
This study evaluates the safety and effectiveness of Brenipatide for people with depression.
This study evaluates the safety and effectiveness of Brenipatide for people with schizophrenia.
A Study of Brenipatide in Participants With Alcohol Use Disorder
Read the official source — NCT07219953A Phase 3, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Alcohol Use Disorder (RENEW-ALC-2)
This study evaluates the safety and effectiveness of Seltorexant for people with depression.
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.